N-acetylcysteine does not influence the activity of endothelium-derived relaxing factor in vivo

Hypertension

Volumn 29, Issue 2, 1997, Pages 668-672

  Creager, Mark A ^a,b   Roddy, Mary Anne ^a   Boles, Kimberly ^a   Stamler, Jonathan S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

endothelium derived relaxing factor; forearm blood flow; N(G) monomethyl L arginine; N acetylcysteine; nitric oxide

Indexed keywords

ACETYLCYSTEINE; ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE;

ADULT; ARTICLE; BIOASSAY; BLOOD VESSEL REACTIVITY; FEMALE; HUMAN; HYPERTENSION; MALE; NORMAL HUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

EID: 0031017903     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.2.668     Document Type: Article

References (41)

1. Furchgott RF, Zawadzki JV, Cherry PD. Role of the endothelium in the vasodilator response to acetylcholine. In: Vanhoutte PM, Leusen I, eds. Vasodilation. New York, NY: Raven Press Publishers; 1981:49-66.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
3. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265-9269.
4. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898-1902.
5. Myers PR, Minor RL, Guerra R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature. 1990; 345:161-163.
6. Greenberg SG, Wilcox DE, Rubanyi GM. Endothelium-derived relaxing factor released from canine femoral artery by acetylcholine cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy. Circ Res. 1990;67:1446-1452.
7. Angus JA, Cocks TM. Endothelium-denved relaxing factor. Pharmacol Ther. 1989;41:303-351.
8. Furchgott RF, Jothianandan D, Khan MT. Comparison of nitric oxide, S-nitrosocysteine and EDRF as relaxants of rabbit aorta. Jpn J Pharmacol. 1992;58:185P-191P.
9. 2 and endothelium-dependent cerebral ar teriolar dilation. Hypertension. 1990;16:162-169.
10. Stamler JS, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, Loscalzo J. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res. 1989; 65:789-795.
11. Cooke JP, Stamler JS, Andon N, Davies PF, Loscalzo J. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol. 1990;28:H804-H812.
12. Feelisch M, tePoel M, Zamora R, Oeussen A, Moncada S. Under-standing the controversy over the identity of EDRF. Nature. 1994; 368:62-65.
13. Stamler JS, Simon DI, Osborne J, Mullins M, Jaraki O, Michel T, Singel D, Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA. 1992;89:444-448.
14. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A. 1992;89:7674-7677.
15. Keaney JF, Simon DI, Stamler JS, Jaraki O, Scharfstein J, Vita JA, Loscalzo J. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest. 1993; 91:1582-1589.
16. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D, Mullins ME, Sugarbaker DJ, Chee C, Singel DJ, Loscalzo J, Stamler JS. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA. 1993;90:10957-10961.
17. Stamler JS, Loh E, Roddy MA, Hoffmann KF, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in normal humans. Circulation. 1994;89:2035-2040.
18. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
19. Sellke FW, Myers PR, Bates JN, Harrison DG. Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycenn. Am J Physiol. 1990;258:H515-H520.
20. Gaston B, Drazen J, Jansen A, Sugarbaker DA, Loscalzo J, Richards W, Stamler JS. The relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther. 1994;268:978-984.
21. Liu X, Martin W, Gillespie JS. Role of S-nitrosothiols in non-adrenergic non-cholinergic relaxation of the bovine retractor penis muscle. Endothelium. 1993;1:238. Abstract.
22. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990; 86:228-234.
23. Fung H-L, Chong S, Kowaluk E, Hough K, Kakemi M. Mechanisms for the pharmacologic interaction of organic nitrates with thiols: Existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acetylcysteine. J Pharmacol Exp Ther. 1988;345: 524-531.
24. Hokanson DE, Sumner DS, Strandness DE Jr. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng. 1975;22:25-29.
25. Furchgott RF, Khan MT, Jothianandan D. Comparison of properties of nitric oxide and endothelium-derived relaxing factor: some cautionary findings. In: Rubanyi GM, Vanhoutte PM, eds. Endothelium-derived Relaxing Factors. Basel, Switzerland: Karger; 1990:8-21.
26. Jia L, Furchgott RF. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1993;267:371-378.
27. Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol. 1987;139:19-30.
28. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989;65:1-21.
29. Stamler JS, Loscalzo J. The antithrombotic effects of organic nitrates. Trends Cardiovasc Med. 1991;1:346-353.
30. Stamler JS. S-nitrosothiols and bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr Top Microbiol Immunol 1995;196:19-36.
31. Daley WL, Loscalzo J, Vita J, Folts J, Stamler JS. The effects of thiol on the hemodynamic profile of nitroprusside: mechanistic implications in vivo. Circulation. 1992;86(suppl I):I-488. Abstract.
32. Scharfstein JS, Keaney JF, Slivka A, Welch GN, Vita JA, Stamler JS, Loscalzo J. In vitro transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest. 1994;94:1432-1439.
33. Mulsch A, Mordvintcev P, Vanin AF, Busse R. The potent vasodilating and guanylyl cyclase activating dinitrosyl-iron(II) complex is stored in a protein-bound form in vascular tissue and is released by thiols. FEBS Lett. 1993;294:252-256.
34. Vanin AF. Endothelium derived relaxing factor is a nitrosyl iron complex with thiol ligands. FEBS Lett. 1991;289:1-3.
35. Lipton SA, Choi YB, Sizheg ZL, Loscalzo J, Singel D, Stamler JS. A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626-632.
36. Morris SL, Hansen JN. Inhibition of Bacillus cereus spore outgrown by covalent modifications of a sulfhydryl group by nitrosothiol and iodoacetate. J Bacteriol. 1981;148:465-471.
37. Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature. 1992; 358:676-678.
38. Kowaluk EA, Fung HL. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther. 1990;255:1256-1264.
39. Radomski MW, Rees DD, Durta A, Moncada S. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol. 1993;107:745-749.
40. Simon DI, Stamler JS, Jaraki O, Keaney J, Osborne JA, Francis SA, Single DJ, Loscalzo J. Antiplatelet properties of protein S-nitrosothiols derived relaxing factor. Anerioscler Thromb. 1993; 13:791-799.
41. Askew SC, Butler AR, Flitney FW, Kemp GD, Megson IL. Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione. Bioorg Med Chem. 1995;3:1-9.